These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 179410)

  • 1. Proceedings: Bone demineralization in renal failure: a longitudinal study of the distal femur using photon absorptiometry.
    Overton TR; Silverberg DS
    AJR Am J Roentgenol; 1976 Jun; 126(6):1289-91. PubMed ID: 179410
    [No Abstract]   [Full Text] [Related]  

  • 2. Questions on the use of vitamin D3.
    Balsan S; Steendijk R
    Pediatrics; 1980 Sep; 66(3):483-4. PubMed ID: 7422447
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of I,25-dihydroxycholecalciferol in renal osteodystrophy.
    Silverberg DS; Bettcher KB; Dossetor JB; Overton TR; Holick MF; DeLuca HF
    Can Med Assoc J; 1975 Jan; 112(2):190, 193-5. PubMed ID: 1111876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of renal osteodystrophy in children with dihydrotachysterol and 24,25-dihydroxyvitamin D3.
    van Diemen-Steenvoorde R; Donckerwolcke RA; Bosch R; Visser WJ; Raymakers JA; Duursma SA
    Clin Nephrol; 1985 Dec; 24(6):292-9. PubMed ID: 3878249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of renal osteodystrophy with calciferol (vitamin D) and related steroids.
    Brickman AS; Norman AW
    Kidney Int; 1973 Aug; 4(2):161-7. PubMed ID: 4364427
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term therapy of uremic osteodystrophy in adults with calcitriol.
    Moorthy AV; Harrington AR; Mazess RB; Simpson DP
    Clin Nephrol; 1981 Aug; 16(2):93-100. PubMed ID: 6894893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: The use of metabolically-active derivatives of vitamin D in rickets and osteomalacia due to renal glomerular failure.
    Smith R; Henderson RG; Russell RG
    J Bone Joint Surg Br; 1975 May; 57(2):247-8. PubMed ID: 1141297
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized double blind study of 1, 25(OH)2D3 in dialysis patients.
    Maxwell DR; Benjamin DM; Donahay SL; Allen MK; Hamburger RJ; Luft FC; Kleit SA
    Proc Clin Dial Transplant Forum; 1977; 7():166-9. PubMed ID: 210446
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hydroxylated metabolites of vitamin D. Therapeutic use of calcitriol and dihydrotachysterol].
    Stĕpán J; Lachmanová J; Wilczek H; Straková M; Zichová M; Horn V; Tomásek R; Pacovský V
    Cas Lek Cesk; 1985 Dec; 124(50):1550-6. PubMed ID: 3841297
    [No Abstract]   [Full Text] [Related]  

  • 10. 1alpha-hydroxychloecalciferol treatment of long-term hemodialyzed patients. Effects on mineral metabolism, bone mineral content and bone morphometry.
    Nielsen HE; Melsen F; Christensen MS; Hansen HE; Rodbro P; Johannsen A
    Clin Nephrol; 1977 Oct; 8(4):429-34. PubMed ID: 923161
    [No Abstract]   [Full Text] [Related]  

  • 11. A model for clinical research studies of renal osteodystrophy in children.
    Norman ME; Mazur A; Gruskin AB
    Arch Intern Med; 1978 May; 138 Spec No():866-8. PubMed ID: 646576
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: Effect of dihydrotachysterol on azotemic renal osteodystrophy.
    Kawaguchi Y; Sakai S; Ogura Y; Kimura Y; Yamamoto M
    Calcif Tissue Res; 1974; 15(2):160. PubMed ID: 4844400
    [No Abstract]   [Full Text] [Related]  

  • 13. The metabolism of vitamin D; recent developments and their clinical relevance.
    Steendijk R
    Neth J Med; 1974; 17(3):131-9. PubMed ID: 4367820
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of renal osteodystrophy].
    Duursma SA; Dorhout Mees EJ
    Ned Tijdschr Geneeskd; 1978 Mar; 122(11):373-8. PubMed ID: 634388
    [No Abstract]   [Full Text] [Related]  

  • 15. 1,25-dihydroxycholesterol treatment of long-term haemodialysed patients with renal osteodystrophy.
    Váry L
    Int Urol Nephrol; 1980; 12(3):241-7. PubMed ID: 7251289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: The effect of chronic renal failure and maintenance hemodialysis on bone mineral content of the radius.
    Parfitt AM; Oliver I; Walczak N; Levin N; Santiago G; Cruz C
    AJR Am J Roentgenol; 1976 Jun; 126(6):1292-3. PubMed ID: 179412
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone maturation in children with chronic renal failure. Effect of 1 alpha-hydroxy vitamin D3 and renal transplantation.
    Johannsen A; Nielsen HE; Hansen HE
    Acta Radiol Diagn (Stockh); 1979; 20(1):193-9. PubMed ID: 377915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of uremic osteodystrophy].
    Fletti C; Docci D; Coli' L; Di Felice A
    G Clin Med; 1981 Apr; 62(4):270-9. PubMed ID: 7021295
    [No Abstract]   [Full Text] [Related]  

  • 19. Does uremic bone disease warrant early treatment with calcitriol?
    Chesney RW
    Arch Intern Med; 1980 Aug; 140(8):1016-7. PubMed ID: 6893117
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mineral content of the skeleton in chronic kidney insufficiency treated with dialysis and after kidney transplantation. Results of isotope densitometry].
    Mujagic M; Flury W; Descoeudres C; Montandon A; Debrunner HU
    Schweiz Med Wochenschr; 1977 Oct; 107(42):1487-92. PubMed ID: 335506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.